Validation of Long-term Benefits of Bivalirudin vs. Unfractionated Heparin in Routine Clinical Practice after Percutaneous Coronary Intervention

Randomized controlled trials have shown improved short-term bleeding outcomes for bivalirudin relative to unfractionated heparin (UFH) in patients undergoing percutaneous coronary intervention (PCI) for stable angina and acute coronary syndrome. This study analyzed the impact of bivalirudin based an...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Vidi, Venkatesan D., Matheny, Michael E., Agarwal, Vikram, Arora, Nipun, Donnelly, Sharon, Bangalore, Sripal, Resnic, Frederic S.
Format: Artigo
Jezik:Inglês
Izdano: 2010
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2966846/
https://ncbi.nlm.nih.gov/pubmed/21029818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2010.06.047
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items